Withdrawn: Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer’s disease
By ACA |
The Publisher regrets that this article is an accidental duplication of an article that has already been published, DOI of ...
Read More WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer’s disease: Emerging evidence from translational and clinical research
By ACA |
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this ...
Read More Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance
By ACA |
Several concepts, which in the aggregate get might be used to account for “resilience” against age- and disease-related changes, have ...
Read More Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study
By ACA |
The easily-imaged retinal microvasculature may reflect the brain microvasculature and therefore be related to dementia.
Read More Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer’s disease
By ACA |
We investigated the proteomic profiles of amyloid plaques (APs) from Alzheimer's disease (AD) and age-matched non-AD brains and APP/PS1 transgenic ...
Read More Longitudinal study of hearing loss and subjective cognitive function decline in men
By ACA |
We examined the relation between self-reported hearing loss, hearing aid use, and risk of subjective cognitive function (SCF) decline.
Read More Alzheimer’s disease and glaucoma: Look-alike neurodegenerative diseases
By ACA |
We read with great interest the article by Lee et al. [1] entitled “Associations between recent and established ophthalmic conditions and ...
Read More Early versus late MCI: Improved MCI staging using a neuropsychological approach
By ACA |
The Alzheimer's Disease Neuroimaging Initiative (ADNI) separates “early” and “late” mild cognitive impairment (MCI) based on a single memory test. ...
Read More Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)
By ACA |
A small percentage of Alzheimer's disease (AD) cases are caused by genetic mutations with autosomal dominant inheritance. We report a ...
Read More Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer’s disease
By ACA |
The relative importance of structural magnetic resonance imaging (MRI) and tau positron emission tomography (PET) to predict diagnosis and cognition ...
Read More